OPHTHOTECH CORP's ticker is OPHT and the CUSIP is 683745103. A total of 73 filers reported holding OPHTHOTECH CORP in Q2 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $61,000 | +17.3% | 43,600 | 0.0% | 0.00% | – |
| Q4 2018 | $52,000 | -49.5% | 43,600 | 0.0% | 0.00% | – |
| Q3 2018 | $103,000 | -13.4% | 43,600 | 0.0% | 0.00% | – |
| Q2 2018 | $119,000 | 0.0% | 43,600 | 0.0% | 0.00% | – |
| Q1 2018 | $119,000 | -12.5% | 43,600 | 0.0% | 0.00% | – |
| Q4 2017 | $136,000 | +10.6% | 43,600 | 0.0% | 0.00% | – |
| Q3 2017 | $123,000 | +9.8% | 43,600 | 0.0% | 0.00% | – |
| Q2 2017 | $112,000 | -30.0% | 43,600 | 0.0% | 0.00% | – |
| Q1 2017 | $160,000 | -27.3% | 43,600 | -4.2% | 0.00% | – |
| Q4 2016 | $220,000 | -89.5% | 45,500 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $2,099,000 | +211.9% | 45,500 | +285.9% | 0.00% | +200.0% |
| Q1 2015 | $673,000 | 0.0% | 11,790 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $673,000 | -77.9% | 11,790 | -83.6% | 0.00% | -75.0% |
| Q2 2014 | $3,049,000 | +9735.5% | 72,062 | +7106.2% | 0.00% | – |
| Q4 2013 | $31,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,103,981 | $44,734,000 | 25.02% |
| Novo Holdings A/S | 4,910,487 | $198,973,000 | 20.56% |
| JHL Capital Group LLC | 3,265,000 | $132,298,000 | 14.62% |
| AlpInvest Partners B.V. | 111,519 | $4,519,000 | 8.90% |
| Opaleye Management Inc. | 105,000 | $4,255,000 | 2.09% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 16,110 | $653,000 | 2.05% |
| IMA Wealth, Inc. | 66,061 | $2,623,000 | 1.66% |
| WILLIAM HARRIS INVESTORS INC | 143,022 | $5,795,000 | 1.64% |
| Orbimed Advisors | 1,923,500 | $77,940,000 | 0.79% |
| Overbrook Management Corp | 117,807 | $4,774,000 | 0.74% |